New alliance sees GlaxoSmithKline and UCL Institute of Ophthalmology share compound research
GlaxoSmithKline (GSK) and University College London’s Institute of Ophthalmology (UCL IoO) have entered into a three-year strategic collaboration to investigate new compounds to treat potentially sight-threatening disorders.
